Patents by Inventor Jayasree Vasudevan

Jayasree Vasudevan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
    Patent number: 6147224
    Abstract: Compounds of Formula 1, Formula 2 or Formula 3 where X is O, S, or (CR.sub.1 R.sub.1).sub.n where n is 0, 1 or 2; Y is a bivalent radical having Formula 4 or Formula 5 where o is an integer from 1 to 4 ##STR1## or Y is a bivalent aryl or 5 or 6 membered heteroaryl radical having 1 to 3 heteroatoms selected from N, S and O, said aryl or heteroaryl groups being unsubstituted, or substituted with 1 to 3 C.sub.1-6 alkyl or with 1 to 3 C.sub.1-6 fluoroalkyl groups; and the remaining symbols have the meaning described in the specification, have RXR selective retinoid agonist-like activity.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: November 14, 2000
    Assignee: Allergan Sales, Inc.
    Inventors: Vidyasagar Vuligonda, Kwok Yin Tsang, Jayasree Vasudevan, Roshantha A. Chandraratna
  • Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
    Patent number: 6093838
    Abstract: Compounds of Formula 1 and of Formula 2 ##STR1## where the symbols have the meaning defined in the specification, have retinoid-like biological activity.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: July 25, 2000
    Assignee: Allergan Sales, Inc.
    Inventors: Jayasree Vasudevan, Richard L. Beard, Dehua Huang, Roshantha A. Chandraratna
  • Tetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activity
    Patent number: 6048873
    Abstract: Compounds of Formula 1 ##STR1## where Y is a bivalent radical having Formula 2 or Formula 3 where o is an integer from 1 to 4 ##STR2## where the remaining symbols have the meaning described in the specification are selective agonists of RXR retinoid receptors.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: April 11, 2000
    Assignee: Allergan Sales, Inc.
    Inventors: Jayasree Vasudevan, Vidyasagar Vuligonda, Richard L. Beard, Roshantha A. Chandraratna